Discovery of pyrimidines and intermediates as a human epidermal growth factor receptor (HER-2) and Apurinic/Apyrimidinic Endonuclease-1 (APE-1) inhibitors for breast cancer therapy: An synthetic approach

Accessibility Controls

Principal Investigator

Dr. Guru Basavaraja Swamy

Associate Professor, Acharya Institute of Technology, Bengaluru, Karnataka

Area of Research

Pharmaceutical Sciences

Focus Area

HER-2 and APE-1 inhibitors for breast cancer

Start Date

2017

Sanction Amount

₹ 31.01 L

Contact

gurubasavaraj@acharya.ac.in

No. of Research Paper

Technologies (If Any)

No. of PhD Produced

Publications

No. of Patents

Filed : 00

Grant : 00

Accessibility Controls